Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avert is the animal health division of Biolab focused on companion animal products for dogs and cats. The business develops and markets veterinary medicines, supplements, nutraceuticals, and dermocosmetic products, with a portfolio of more than 90 presentations and a stated position among the top 10 companies in Brazil's veterinary pharmaceutical market. Its offerings span gastrointestinal, dermatology, joint health, behavior, critical care, omega-3, and related pet wellness categories. Avert appears to be a commercial-stage operating brand/business unit rather than a therapeutics R&D biotech company, and its activities are centered on veterinary product commercialization and expansion in Brazil and selected international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avert.